Login / Signup
Impact of Obesity on the Drug-Drug Interaction Between Dolutegravir and Rifampicin or Any Other Strong Inducers.
Mattia Berton
Sara Bettonte
Felix Stader
Manuel Battegay
Catia Marzolini
Published in:
Open forum infectious diseases (2023)
.
Keyphrases
</>
metabolic syndrome
insulin resistance
mycobacterium tuberculosis
type diabetes
weight loss
weight gain
high fat diet induced
body mass index
physical activity